Cited by 349Protease and Inhibitor MechanismsCellular Mechanics and InteractionsTGF-β signaling in diseases

The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.

Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression

Open access

Brassart-Pasco, Sylvie, Brézillon, Stéphane, Brassart, Bertrand, Ramont, Laurent, Oudart, Jean-Baptiste, Monboisse, Jean Claude·2020·Frontiers in Oncology

DOI 10.3389/fonc.2020.00397PMC PMC7174611

Open this paper in CoChat — free account Open PDF

Abstract

The tumor microenvironment (TME) is composed of various cell types embedded in an altered extracellular matrix (ECM). ECM not only serves as a support for tumor cell but also regulates cell-cell or cell-matrix cross-talks. Alterations in ECM may be induced by hypoxia and acidosis, by oxygen free radicals generated by infiltrating inflammatory cells or by tumor- or stromal cell-secreted proteases. A poorer diagnosis for patients is often associated with ECM alterations. Tumor ECM proteome, also named cancer matrisome, is strongly altered, and different ECM protein signatures may be defined to serve as prognostic biomarkers. Collagen network reorganization facilitates tumor cell invasion. Proteoglycan expression and location are modified in the TME and affect cell invasion and metastatic dissemination. ECM macromolecule degradation by proteases may induce the release of angiogenic growth factors but also the release of proteoglycan-derived or ECM protein fragments, named matrikines or matricryptins. This review will focus on current knowledge and new insights in ECM alterations, degradation, and reticulation through cross-linking enzymes and on the role of ECM fragments in the control of cancer progression and their potential use as biomarkers in cancer diagnosis and prognosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3389/fonc.2020.00397

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Human 1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by 1 1 integrin
Sudhakar, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24813 · Cited by 162
Retracted
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Metabolic Interactions in the Tumor Microenvironment
Lyssiotis, C. A., & Kimmelman, A. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.06.003 · Cited by 853 · cited 1×
“By inducing specific gene expression, it alters the cellular metabolism, increasing glycolysis and lactate production (11, 12).”
Background
Tumor-Associated Neutrophils: New Targets for Cancer Therapy
Gregory, A. D., & Houghton, A. M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2583 · Cited by 703
The extracellular matrix in tumor progression and metastasis
Eble, J. A., & Niland, S. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09966-1 · Cited by 613
Therapeutic targeting of the tumor microenvironment
Joyce, J. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.05.024 · Cited by 598
Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin
Hamano, Y., Zeisberg, M., Sugimoto, H., Lively, J. C., Maeshima, Y., Yang, C., Hynes, R. O., Werb, Z., Sudhakar, A., & Kalluri, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00133-8 · Cited by 566
Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology
Cyphert, J. M., Trempus, C. S., & Garantziotis, S. (2015) · International Journal of Cell Biology · doi:10.1155/2015/563818 · Cited by 423
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
Zhou, F., Shang, W., Yu, X., & Tian, J. (2017) · Medicinal Research Reviews · doi:10.1002/med.21455 · Cited by 401
A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer
Lai, X., Wang, M., McElyea, S. D., Sherman, S., House, M. G., & Korc, M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.019 · Cited by 395
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Karamanos, N. K., Piperigkou, Z., Theocharis, A. D., Watanabe, H., Franchi, M., Baud, S., Brézillon, S., Götte, M., Passi, A. G., Vigetti, D., et al. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00354 · Cited by 380
Self-citation
Endorepellin, a Novel Inhibitor of Angiogenesis Derived from the C Terminus of Perlecan
Mongiat, M., Sweeney, S. M., Antonio, J. D. S., Fu, J., & Iozzo, R. V. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210445200 · Cited by 341
The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering
Yang, C., Cao, M., Liu, H., He, Y., Xu, J., Du, Y., Liu, Y., Wang, W., Cui, L., Hu, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.349209 · Cited by 304
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Sawada, Y., Yoshikawa, T., Nobuoka, D., Shirakawa, H., Kuronuma, T., Motomura, Y., Mizuno, S., Ishii, H., Nakachi, K., Konishi, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3044 · Cited by 302
Antiangiogenic Activity of Restin, NC10 Domain of Human Collagen XV: Comparison to Endostatin
Ramchandran, R., Dhanabal, M., Volk, R., Waterman, M. J. F., Segal, M. S., Lu, H. A. J., Knebelmann, B., & Sukhatme, V. P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0248 · Cited by 290
Syndecan-1 regulates αvβ3 and αvβ5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
Beauvais, D. M., Ell, B. J., McWhorter, A. R., & Rapraeger, A. C. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20081278 · Cited by 290
Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway
Zhou, X., Yan, T., Huang, C., Xu, Z., Wang, L., Jiang, E., Wang, H., Yang, C., Liu, K., Shao, Z., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0911-3 · Cited by 287
ADAMTS Metalloproteases Generate Active Versican Fragments that Regulate Interdigital Web Regression
McCulloch, D. R., Nelson, C. M., Dixon, L. J., Silver, D. L., Wylie, J. D., Lindner, V., Sasaki, T., Cooley, M. A., Argraves, W. S., & Apte, S. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.09.008 · Cited by 258
Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP
Robinet, A., Fahem, A., Cauchard, J.-H., Huet, E., Vincent, L., Lorimier, S., Antonicelli, F., Soria, C., Crépin, M., Hornebeck, W., et al. (2005) · Journal of Cell Science · doi:10.1242/jcs.01613 · Cited by 256
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
Santi, A., Kugeratski, F. G., & Zanivan, S. R. (2017) · PROTEOMICS · doi:10.1002/pmic.201700167 · Cited by 251
Biophysics of tumor microenvironment and cancer metastasis – a mini review
Emon, B., Bauer, J., Jain, Y., Jung, B., & Saif, T. (2018) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2018.07.003 · Cited by 245
Procollagen II Amino Propeptide Processing by ADAMTS-3
Fernandes, R. J., Hirohata, S., Engle, J. M., Colige, A., Cohn, D. H., Eyre, D. R., & Apte, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103466200 · Cited by 230
Two RGD-independent αvβ3 Integrin Binding Sites on Tumstatin Regulate Distinct Anti-tumor Properties
Maeshima, Y., Colorado, P. C., & Kalluri, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000186200 · Cited by 229
A current view of perlecan in physiology and pathology: A mosaic of functions
Gubbiotti, M. A., Neill, T., & Iozzo, R. V. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.09.003 · Cited by 228
mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer
de la Cruz-López, K. G., Toledo-Guzmán, M. E., Sánchez, E. O., & Carrancá, A. G. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01373 · Cited by 223
Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells.
Wickström, S. A., Alitalo, K. K., & Keski‐Oja, J. (2002) · PubMed · Cited by 207
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
Karousou, E. G., Misra, S., Ghatak, S., Dobra, K., Götte, M., Vigetti, D., Passi, A. G., Karamanos, N. K., & Skandalis, S. S. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.10.001 · Cited by 204
GPC 1 exosome and its regulatory mi RNA s are specific markers for the detection and target therapy of colorectal cancer
Li, J., Chen, Y., Guo, X., Zhou, L., Jia, Z., Peng, Z., Tang, Y., Liu, W., Zhu, B., Wang, L., et al. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12941 · Cited by 194
The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis
Nandadasa, S., Foulcer, S. J., & Apte, S. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.01.005 · Cited by 187
Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications
Walia, A., Yang, J., Huang, Y.-H., Rosenblatt, M. I., Chang, J., & Azar, D. T. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.09.007 · Cited by 184
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
Sawada, Y., Yoshikawa, T., Ofuji, K., Yoshimura, M., Tsuchiya, N., Takahashi, M., Nobuoka, D., Gotohda, N., Takahashi, S., Kato, Y., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1129483 · Cited by 178
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
Frampton, A. E., Prado, M. M., López-Jiménez, E. A., Fajardo-Puerta, A. B., Jawad, Z., Lawton, P., Giovannetti, E., Habib, N., Castellano, L., Stebbing, J., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24873 · Cited by 171
The cancer matrisome: From comprehensive characterization to biomarker discovery
Socovich, A. M., & Naba, A. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.06.005 · Cited by 164
Laminin 332 processing impacts cellular behavior
Rousselle, P., & Beck, K. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.23132 · Cited by 160
Canstatin Acts on Endothelial and Tumor Cells via Mitochondrial Damage Initiated through Interaction with αvβ3 and αvβ5 Integrins
Magnon, C., Galaup, A., Mullan, B., Rouffiac, V., Bidart, J., Griscelli, F., Opolon, P., & Perricaudet, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3536 · Cited by 152
Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator
Καραμάνου, Κ., Franchi, M., Vynios, D. H., & Brézillon, S. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.003 · Cited by 152
Self-citation
Immunoregulatory roles of versican proteolysis in the myeloma microenvironment
Hope, C. L., Foulcer, S. J., Jagodinsky, J. C., Chen, S. X., Jensen, J. L., Patel, S., Leith, C. P., Maroulakou, I. G., Callander, N. S., Miyamoto, S., et al. (2016) · Blood · doi:10.1182/blood-2016-03-705780 · Cited by 147
MT2-MMP-Dependent Release of Collagen IV NC1 Domains Regulates Submandibular Gland Branching Morphogenesis
Rebustini, I. T., Myers, C., Lassiter, K. S., Surmak, A. J., Szabova, L., Holmbeck, K., Pedchenko, V. K., Hudson, B. G., & Hoffman, M. P. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.07.016 · Cited by 146
Fragments generated upon extracellular matrix remodeling: Biological regulators and potential drugs
Ricard‐Blum, S., & Vallet, S. D. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.11.005 · Cited by 145
Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight
Sato, N., Kohi, S., Hirata, K., & Goggins, M. (2016) · Cancer Science · doi:10.1111/cas.12913 · Cited by 142
Next-Generation Cancer Immunotherapy Targeting Glypican-3
Shimizu, Y., Suzuki, T., Yoshikawa, T., Endo, I., & Nakatsura, T. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00248 · Cited by 139
Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers
Poluzzi, C., Iozzo, R. V., & Schaefer, L. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.012 · Cited by 134
Laminin-111-derived peptides and cancer
Kikkawa, Y., Hozumi, K., Katagiri, F., Nomizu, M., Kleinman, H. K., & Koblinski, J. E. (2013) · Cell Adhesion & Migration · doi:10.4161/cam.22827 · Cited by 132
A Frizzled‐Like Cysteine‐Rich Domain in Glypican‐3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice
Li, N., Wei, L., Liu, X., Bai, H., Ye, Y., Li, D., Li, N., Baxa, U., Wang, Q., Lv, L., et al. (2019) · Hepatology · doi:10.1002/hep.30646 · Cited by 130
The Tumor Microenvironment and Strategies to Improve Drug Distribution
Saggar, J. K., Yu, M., Tan, Q., & Tannock, I. F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00154 · Cited by 129
Tumstatin, the NC1 domain of α3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth
Hamano, Y., & Kalluri, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.130 · Cited by 125
αvβ3 and αvβ5 Integrins Bind Both the Proximal RGD Site and Non-RGD Motifs within Noncollagenous (NC1) Domain of the α3 Chain of Type IV Collagen
Pedchenko, V. K., Zent, R., & Hudson, B. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311901200 · Cited by 123
Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma
Lendorf, M. E., Manon‐Jensen, T., Kronqvist, P., Multhaupt, H. A. B., & Couchman, J. (2011) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155411405057 · Cited by 123
Matrikines from basement membrane collagens: A new anti-cancer strategy
Monboisse, J., Oudart, J., Ramont, L., Brassart‐Pasco, S., & Maquart, F. X. (2014) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.12.029 · Cited by 121
Self-citation
Elevated glypican‐1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma
Lu, H., Niu, F., Liu, F., Gao, J., Sun, Y., & Zhao, X. (2017) · Cancer Medicine · doi:10.1002/cam4.1064 · Cited by 119
The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer
Kolluri, A., & Ho, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00708 · Cited by 118
Versican-Derived Matrikines Regulate Batf3–Dendritic Cell Differentiation and Promote T Cell Infiltration in Colorectal Cancer
Hope, C. L., Emmerich, P. B., Papadas, A., Pagenkopf, A. C., Matkowskyj, K. A., Hey, D. R. V. D., Payne, S. N., Clipson, L. J., Callander, N. S., Hematti, P., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700529 · Cited by 117
Heparanase-induced shedding of syndecan-1/CD138 in myeloma and endothelial cells activates VEGFR2 and an invasive phenotype: prevention by novel synstatins
Jung, O., Trapp‐Stamborski, V., Purushothaman, A., Jin, H., Wang, H., Sanderson, R. D., & Rapraeger, A. C. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.5 · Cited by 116
Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients
Kehlet, S. N., Pamplona, R. S., Brix, S., Leeming, D. J., Karsdal, M. A., & Moreno, V. R. (2016) · Scientific Reports · doi:10.1038/srep30599 · Cited by 114
Locally generated VGVAPG and VAPG elastin‐derived peptides amplify melanoma invasion via the galectin‐3 receptor
Pócza, P., Süli‐Vargha, H., Darvas, Z., & Falus, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.23296 · Cited by 113
Degradation of tropoelastin by matrix metalloproteinases – cleavage site specificities and release of matrikines
Heinz, A., Jung, M. C., Duca, L., Sippl, W., Taddese, S., Ihling, C. H., Rusciani, A., Jahreis, G., Weiss, A. S., Neubert, R. H. H., et al. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07616.x · Cited by 112
Lumican effects in the control of tumour progression and their links with metalloproteinases and integrins
Brézillon, S., Pietraszek‐Gremplewicz, K., Maquart, F., & Wegrowski, Y. (2013) · FEBS Journal · doi:10.1111/febs.12210 · Cited by 107
Self-citation
Synstatin: a selective inhibitor of the syndecan‐1‐coupled IGF 1 R –αvβ3 integrin complex in tumorigenesis and angiogenesis
Rapraeger, A. C. (2013) · FEBS Journal · doi:10.1111/febs.12160 · Cited by 104
Metastatin: a hyaluronan-binding complex from cartilage that inhibits tumor growth.
Liu, N., Lapcevich, R., Underhill, C. B., Han, Z., Gao, F., Swartz, G., Plum, S., Zhang, L., & Green, S. J. (2001) · PubMed · Cited by 101
Altered retinoblastoma protein expression in nonsmall cell lung cancer
Dosaka‐Akita, H., Hu, S., Fujino, M., Harada, M., Kinoshita, I., Xu, H., Kuzumaki, N., Kawakami, Y., & Benedict, W. F. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970401)79:7 · Cited by 97
Elastin-Derived Peptides Upregulate Matrix Metalloproteinase-2-ediated Melanoma Cell Invasion Through Elastin-Binding Protein
Ntayi, C., Labrousse, A.-L., Debret, R., Birembaut, P., Bellon, G., Antonicelli, F. D., Hornebeck, W., & Bernard, P. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22228.x · Cited by 95
Serum endostatin levels are elevated in patients with soft tissue sarcoma
Feldman, A. L., Pak, H., Yang, J. C., Alexander, H. R., & Libutti, S. K. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8 · Cited by 92
Lumican inhibits cell migration through α2β1 integrin
Zeltz, C., Brézillon, S., Käpylä, J., Eble, J. A., Bobichon, H., Terryn, C., Perreau, C., Franz, C. M., Heino, J., Maquart, F., et al. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.08.002 · Cited by 91
Self-citation
Vascular endothelial‐cadherin stimulates syndecan‐1‐coupled insulin‐like growth factor‐1 receptor and cross‐talk between α V β3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis
Rapraeger, A. C., Ell, B. J., Roy, M., Li, X., Morrison, O. R., Thomas, G. M., & Beauvais, D. M. (2013) · FEBS Journal · doi:10.1111/febs.12134 · Cited by 83
The Antitumor Properties of the α3(IV)-(185-203) Peptide from the NC1 Domain of Type IV Collagen (Tumstatin) Are Conformation-dependent
Floquet, N., Brassart‐Pasco, S., Ramont, L., Derreumaux, P., Laronze, J. Y., Nuzillard, J., Maquart, F. X., Alix, A. J. P., & Monboisse, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307736200 · Cited by 78
Self-citation
Lumican Binds ALK5 to Promote Epithelium Wound Healing
Yamanaka, O., Yuan, Y., Coulson‐Thomas, V. J., Gesteira, T. F., Call, M. K., Zhang, Y., Zhang, J., Chang, S., Xie, C., Liu, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082730 · Cited by 77
Lumican: A new inhibitor of matrix metalloproteinase‐14 activity
Pietraszek‐Gremplewicz, K., Chatron-Colliet, A., Brézillon, S., Perreau, C., Jakubiak-Augustyn, A., Krotkiewski, H., Maquart, F., & Wegrowski, Y. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.09.040 · Cited by 77
Self-citation
Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the α3β1 Integrin Via Binding Sites in Their Ectodomains
Wang, H., Jin, H., & Rapraeger, A. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679084 · Cited by 75
Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer
Chang, J. W., Kang, U., Kim, D., Yi, J. K., Lee, J. W., Noh, D., Lee, C., & Yu, M. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780049 · Cited by 75
The action of neutrophil serine proteases on elastin and its precursor
Heinz, A., Jung, M. C., Jahreis, G., Rusciani, A., Duca, L., Debelle, L., Weiss, A. S., Neubert, R. H. H., & Schmelzer, C. E. H. (2011) · Biochimie · doi:10.1016/j.biochi.2011.10.006 · Cited by 72
The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy
Douglass, S. M., Goyal, A. K., & Iozzo, R. V. (2015) · Connective Tissue Research · doi:10.3109/03008207.2015.1045297 · Cited by 71
The clinical significance of circulating GPC1 positive exosomes and its regulative miRNAs in colon cancer patients
Li, J., Li, B., Ren, C., Chen, Y., Guo, X., Zhou, L., Peng, Z., Tang, Y., Chen, Y., Liu, W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20516 · Cited by 71
Small leucine-rich proteoglycans and matrix metalloproteinase-14: Key partners?
Pietraszek‐Gremplewicz, K., Καραμάνου, Κ., Niang, A., Dauchez, M., Belloy, N., Maquart, F., Baud, S., & Brézillon, S. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.12.006 · Cited by 71
Self-citation
Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls
Willumsen, N., Bager, C. L., Leeming, D. J., Smith, V., Karsdal, M. A., Dornan, D., & Bay‐Jensen, A. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-554 · Cited by 70
Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma
Naboulsi, W., Megger, D. A., Bracht, T., Kohl, M., Turewicz, M., Eisenacher, M., Voss, D. M., Schlaak, J., Hoffmann, A.-C., Weber, F., et al. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00420 · Cited by 70
Clinical Significance of Serum COL6A3 in Pancreatic Ductal Adenocarcinoma
Kang, C. Y., Wang, J., Axell‐House, D. B., Soni, P., Chu, M., Chipitsyna, G. I., Sarosiek, K., Sendecki, J. A., Hyslop, T., Zoubi, M. S. A., et al. (2013) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-013-2326-y · Cited by 67
Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer.
Herreros‐Villanueva, M., & Bujanda, L. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.10.39 · Cited by 67
Tetrastatin, the NC1 Domain of the α4(IV) Collagen Chain: A Novel Potent Anti-Tumor Matrikine
Brassart‐Pasco, S., Sénéchal, K., Thévenard, J., Ramont, L., Devy, J., Stefano, L. D., Dupont-Deshorgue, A., Brézillon, S., Feru, J., Jazeron, J.-F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029587 · Cited by 66
Self-citation
Identification of novel short peptides derived from the α4, α5, and α6 fibrils of type IV collagen with anti-angiogenic properties
Karagiannis, E. D., & Popel, A. S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.231 · Cited by 66
Targeting microenvironment in cancer therapeutics
Martin, M., Han, W., & Lu, T. (2016) · Oncotarget · doi:10.18632/oncotarget.9824 · Cited by 66
Proteoglycans regulate autophagy via outside-in signaling: an emerging new concept
Gubbiotti, M. A., & Iozzo, R. V. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.10.002 · Cited by 65
Lumican – Derived Peptides Inhibit Melanoma Cell Growth and Migration
Pietraszek‐Gremplewicz, K., Brézillon, S., Perreau, C., Malicka-Błaszkiewicz, M., Maquart, F., & Wegrowski, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076232 · Cited by 65
Self-citation
Collagen degradation by superoxide anion in pulse and gamma radiolysis
Monboisse, J., Gardès-Albert, M., Randoux, A., Jp, B., & Ferradini, C. (1988) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(88)90147-x · Cited by 63
Self-citation
Arresten, a Collagen-Derived Angiogenesis Inhibitor, Suppresses Invasion of Squamous Cell Carcinoma
Aikio, M., Alahuhta, I., Nurmenniemi, S., Suojanen, J., Palovuori, R., Teppo, S., Sorsa, T. A., López-Otı́n, C., Pihlajaniemi, T. A., Salo, T. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051044 · Cited by 61
Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase
Devy, J., Duca, L., Cantarelli, B., Joseph‐Pietras, D., Scandolera, A., Rusciani, A., Parent, L., Thévenard, J., Brassart‐Pasco, S., Tarpin, M., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605926 · Cited by 61
Self-citation
In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model
Brassart‐Pasco, S., Ramont, L., Ventéo, L., Pluot, M., Maquart, F., & Monboisse, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.036 · Cited by 59
Self-citation
Elastokine-mediated up-regulation of MT1-MMP is triggered by nitric oxide in endothelial cells
Fahem, A., Robinet, A., Cauchard, J.-H., Duca, L., Soula-Rothhut, M., Rothhut, B., Soria, C., Guenounou, M., Hornebeck, W., & Bellon, G. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.022 · Cited by 59
Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model
Koskimaki, J. E., Karagiannis, E. D., Tang, B. C., Hammers, H. J., Watkins, D. N., Пили, Р., & Popel, A. S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-29 · Cited by 58
Elevated serum endostatin is associated with poor outcome in patients with non‐Hodgkin lymphoma
Bono, P., Teerenhovi, L. M., & Joensuu, H. (2003) · Cancer · doi:10.1002/cncr.11399 · Cited by 57
Hypoxic Signalling in Tumour Stroma
Laitala, A., & Erler, J. T. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00189 · Cited by 55
Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers
Kantola, T., Väyrynen, J. P., Klintrup, K., Mäkelä, J. T., Karppinen, S., Pihlajaniemi, T. A., Autio‐Harmainen, H., Karttunen, T. J., Mäkinen, M. J., & Tuomisto, A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.456 · Cited by 55
Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II–III colon cancer
Chida, S., Okayama, H., Noda, M., Saito, K., Nakajima, T., Aoto, K., Hayase, S., Momma, T., Ohki, S., Kono, K., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw069 · Cited by 54
Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion
Grahovac, J., & Wells, A. H. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.132 · Cited by 53
The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction
Oudart, J., Doué, M., Vautrin, A., Brassart, B., Sellier, C., Dupont-Deshorgue, A., Monboisse, J., Maquart, F., Brassart‐Pasco, S., & Ramont, L. (2015) · Oncotarget · doi:10.18632/oncotarget.6399 · Cited by 52
Self-citation
Lumcorin: A leucine‐rich repeat 9‐derived peptide from human lumican inhibiting melanoma cell migration
Zeltz, C., Brézillon, S., Perreau, C., Ramont, L., Maquart, F., & Wegrowski, Y. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.08.012 · Cited by 50
Self-citation
Type IV collagen α6 chain‐derived noncollagenous domain 1 (α6(IV)NC1) inhibits angiogenesis and tumor growth
Mundel, T. M., Yliniemi, A., Maeshima, Y., Sugimoto, H., Kieran, M. W., & Kalluri, R. (2007) · International Journal of Cancer · doi:10.1002/ijc.23269 · Cited by 49
Type IIB Procollagen NH2-propeptide Induces Death of Tumor Cells via Interaction with Integrins αVβ3 and αVβ5
Wang, Z., Bryan, J., Franz, C., Havlioglu, N., & Sandell, L. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118521 · Cited by 49
Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma
Suzuki, S., Sakata, J., Utsumi, F., Sekiya, R., Kajiyama, H., Shibata, K., Kikkawa, F., & Nakatsura, T. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1238542 · Cited by 49
Elastin Fragments Induce IL-1β Upregulation via NF-κB Pathway in Melanoma Cells
Debret, R., Naour, R. L., Sallenave, J., Dupont-Deshorgue, A., Hornebeck, W., Guenounou, M., Bernard, P., & Antonicelli, F. D. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700337 · Cited by 48
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy
Nobuoka, D., Yoshikawa, T., Takahashi, M., Iwama, T., Horie, K., Shimomura, M., Suzuki, S., Sakemura, N., Nakatsugawa, M., Sadamori, H., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1366-6 · Cited by 48
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
Cortes‐Dericks, L., & Schmid, R. A. (2017) · Respiratory Research · doi:10.1186/s12931-017-0546-5 · Cited by 47
Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer
Kulbe, H., Otto, R., Darb‐Esfahani, S., Lammert, H., Abobaker, S., Welsch, G., Chekerov, R., Schäfer, R., Dragun, D., Hummel, M., et al. (2019) · Cells · doi:10.3390/cells8070713 · Cited by 46
Endostatin: Current concepts about its biological role and mechanisms of action
Дигтярь, А. В., Pozdniakova, N. V., Feldman, N. B., Lutsenko, S. V., & Severin, E. S. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907030017 · Cited by 46
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer
Szarvas, T., László, V., Dorp, F. V., Reis, H., Szendrői, A., Romics, I., Derya Tilki, A., Rubben, H., & Ergün, S. (2011) · International Journal of Cancer · doi:10.1002/ijc.26343 · Cited by 46
A current perspective of canstatin, a fragment of type IV collagen alpha 2 chain
Okada, M., & Yamawaki, H. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.12.001 · Cited by 46
Endorepellin-evoked Autophagy Contributes to Angiostasis
Goyal, A., Gubbiotti, M. A., Chery, D. R., Han, L., & Iozzo, R. V. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.740266 · Cited by 44
Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis
Shen, Z., Yao, C., Wang, Z., Yue, L., Fang, Z., Yao, H., Feng, L., Zhao, H., Sun, Y.-J., Bian, X., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.56 · Cited by 43
Lumican Peptides: Rational Design Targeting ALK5/TGFBRI
Gesteira, T. F., Coulson‐Thomas, V. J., Yuan, Y., Zhang, J., Nader, H. B., & Kao, W. W. ‐. (2017) · Scientific Reports · doi:10.1038/srep42057 · Cited by 43
Tumour cell blebbing and extracellular vesicle shedding: key role of matrikines and ribosomal protein SA
Brassart, B., silva, J. D., Donet, M., Seurat, E., Hague, F., Terryn, C., Velard, F., Michel, J., Ouadid‐Ahidouch, H., Monboisse, J., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0382-0 · Cited by 43
Self-citation
Anastellin, the Angiostatic Fibronectin Peptide, Is a Selective Inhibitor of Lysophospholipid Signaling
Ambesi, A., & McKeown‐Longo, P. J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0195 · Cited by 42
Prognostic Value of ADAMTS Proteases and Their Substrates in Epithelial Ovarian Cancer
Lima, M. A., dos Santos, L., Turri, J. A. O., Nonogaki, S., Buim, M. E. C., Lima, J. F., Pinheiro, J. D. J. V., Osório, C. A. B. D. T., Soares, F. A., & Freitas, V. M. (2016) · Pathobiology · doi:10.1159/000446244 · Cited by 40
Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients
Tang, C., Liu, Y., Qin, H., Li, X., Guo, W., Li, J., Wang, W., Qu, L., Hu, H., Xu, C., et al. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.09.011 · Cited by 38
Type XIX collagen: A new partner in the interactions between tumor cells and their microenvironment
Oudart, J., Monboisse, J., Maquart, F., Brassart, B., Brassart‐Pasco, S., & Ramont, L. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.07.010 · Cited by 38
Self-citation
Status of and prospects for cancer vaccines against hepatocellular carcinoma in clinical trials
Sun, Z., Zhu, Y., Xia, J., Sawakami, T., Kokudo, N., & Zhang, N. (2015) · BioScience Trends · doi:10.5582/bst.2015.01128 · Cited by 37
Laminin-111 derived peptides AG73 and C16 regulate invadopodia activity of a human adenoid cystic carcinoma cell line
Nascimento, C. F., de Siqueira, A. S., Pinheiro, J. D. J. V., Freitas, V. M., & Jaeger, R. G. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.08.022 · Cited by 37
Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer
Rangel, M. P., de Sá, V. K., Prieto, T. G., Martins, J. R. M., Olivieri, E. R., Carraro, D. M., Takagaki, T. Y., & Capelozzi, V. L. (2018) · Glycoconjugate Journal · doi:10.1007/s10719-018-9815-x · Cited by 37
Matrix Metalloprotease Generated Fragments of Type VI Collagen Have Serum Biomarker Potential in Cancer – A Proof of Concept Study
Willumsen, N., Bager, C. L., & Karsdal, M. A. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.02.004 · Cited by 37
IKVAV regulates ERK1/2 and Akt signalling pathways in BMMSC population growth and proliferation
Li, B., Qiu, T., Zhang, P., Wang, X., Yin, Y., & Li, S. (2014) · Cell Proliferation · doi:10.1111/cpr.12094 · Cited by 36
Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
Grindel, B. J., Li, Q., Arnold, R. S., Petros, J. A., Zayzafoon, M., Muldoon, M., Stave, J. W., Chung, L. W. K., & Farach‐Carson, M. C. (2016) · Oncotarget · doi:10.18632/oncotarget.7197 · Cited by 33
Tumstatin, a Matrikine Derived from Collagen Type IVα3, is Elevated in Serum from Patients with Non–Small Cell Lung Cancer
Nielsen, S. H., Willumsen, N., Brix, S., Sun, S., Manon‐Jensen, T., Karsdal, M. A., & Genovese, F. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.02.005 · Cited by 32
Hyaluronic acid-CD44 interactions promote BMP4/7-dependent Id1/3 expression in melanoma cells
Wu, R., Sedlmeier, G., Kyjacová, L., Schmaus, A., Philipp, J., Thiele, W., Garvalov, B. K., & Sleeman, J. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-33337-7 · Cited by 32
Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition
Lambert, É., Fuselier, E., Ramont, L., Brassart, B., Dukic, S., Oudart, J., Dupont-Deshorgue, A., Sellier, C., Rodrigues, C. M., Dauchez, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28003-x · Cited by 31
Self-citation
Lamstatin – a novel inhibitor of lymphangiogenesis derived from collagen IV
Weckmann, M., Moir, L. M., Heckman, C. A., Black, J. L., Oliver, B. G. G., & Burgess, J. K. (2012) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2012.01648.x · Cited by 30
Degradation of tropoelastin and skin elastin by neprilysin
Huertas, A. C. M., Schmelzer, C. E. H., Luise, C., Sippl, W., Pietzsch, M., Hoehenwarter, W., & Heinz, A. (2017) · Biochimie · doi:10.1016/j.biochi.2017.11.018 · Cited by 30
Inhibition of Wnt/β-Catenin Signaling by a Soluble Collagen-Derived Frizzled Domain Interacting with Wnt3a and the Receptors Frizzled 1 and 8
Hendaoui, I., Lavergne, E., Lee, H.-S., Hong, S. H., Kim, H.-Z., Parent, C., Heuzé‐Vourc'h, N., Clément, B., & Musso, O. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030601 · Cited by 29
Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model
Li, Y., Li, J., Woo, P. Y. M., Shen, Z., Yao, H., Cai, Y., Lin, M. C.-M., & Poon, W. S. (2017) · BMC Cancer · doi:10.1186/s12885-017-3125-8 · Cited by 28
Metabolic adaptation to cancer growth: From the cell to the organism
Escoté, X., & Fajas, L. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.03.034 · Cited by 27
Structural and Antitumor Properties of the YSNSG Cyclopeptide Derived from Tumstatin
Thévenard, J., Floquet, N., Ramont, L., Prost, É., Nuzillard, J., Dauchez, M., Yezid, H., Alix, A. J. P., Maquart, F., Monboisse, J., et al. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.10.007 · Cited by 27
Self-citation
The immunomodulatory role of tumor Syndecan-1 (CD138) on ex vivo tumor microenvironmental CD4+ T cell polarization in inflammatory and non-inflammatory breast cancer patients
Saleh, M. E., Gadalla, R., Hassan, H., Afifi, A., Götte, M., El‐Shinawi, M., Mohamed, M. M., & Ibrahim, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217550 · Cited by 26
Plasmin releases the anti-tumor peptide from the NC1 domain of collagen XIX
Oudart, J., Brassart‐Pasco, S., Vautrin, A., Sellier, C., Rodrigues, C. M., Dupont-Deshorgue, A., Brassart, B., Baud, S., Dauchez, M., Monboisse, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2849 · Cited by 26
Self-citation
Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets
Adamia, S., Pilarski, P. M., Belch, A. R., & Pilarski, L. M. (2013) · Current Cancer Drug Targets · doi:10.2174/1568009611313040001 · Cited by 26
Serum cross‐linked carboxyterminal telopeptide of type I collagen (ICTP) as a prognostic tumor marker in patients with esophageal squamous cell carcinoma
Nabeya, Y., Shimada, H., Okazumi, S., Matsubara, H., Gunji, Y., Suzuki, T., & Ochiai, T. (2002) · Cancer · doi:10.1002/cncr.10267 · Cited by 26
Inhibition of the signaling pathway of syndecan-1 by synstatin: A promising anti-integrin inhibitor of angiogenesis and proliferation in HCC in rats
Metwaly, H. A., El-Gayar, A. M., & El‐Shishtawy, M. M. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.06.007 · Cited by 26
VLA-4 phosphorylation during tumor and immune cell migration relies on its coupling to VEGFR2 and CXCR4 by syndecan-1
Jung, O., Beauvais, D. M., Adams, K. M., & Rapraeger, A. C. (2019) · Journal of Cell Science · doi:10.1242/jcs.232645 · Cited by 24
Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73
Lu, Z., Jiao, D., Qiao, J., Yang, S., Yan, M., Cui, S., & Liu, Z. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0370-9 · Cited by 24
Endorepellin remodels the endothelial transcriptome toward a pro-autophagic and pro-mitophagic gene signature
Neill, T., Andreuzzi, E., Wang, Z., Peiper, S. C., Mongiat, M., & Iozzo, R. V. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002934 · Cited by 23
Cathepsin S degrades arresten and canstatin in infarcted area after myocardial infarction in rats
Sugiyama, A., Mitsui, A., Okada, M., & Yamawaki, H. (2019) · Journal of Veterinary Medical Science · doi:10.1292/jvms.18-0674 · Cited by 22
Crystal Structure of the LG3 Domain of Endorepellin, an Angiogenesis Inhibitor
Le, B. V., Kim, H., Choi, J., Kim, J.-H., Hahn, M., Lee, C., Kim, K. K., & Hwang, H. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.09.048 · Cited by 20
Urinary laminin fragments as a tumour marker potentially reflecting basement membrane destruction
Katayama, M., Kamihagi, K., Hirai, S., Kurome, T., Murakami, K., Hino, F., & Kato, I. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.105 · Cited by 20
Non-invasive profiling of protease-specific elastin turnover in lung cancer: biomarker potential
Thorlacius‐Ussing, J., Kehlet, S. N., Rønnow, S. R., Karsdal, M. A., & Willumsen, N. (2018) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-018-2799-x · Cited by 20
Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm
Park, Y. S., Kim, D. S., Cho, S. W., Park, J. W., Jeon, S. J., Moon, T. J., Kim, S. H., Son, B. K., Oh, T. J., An, S., et al. (2018) · Gut and Liver · doi:10.5009/gnl17357 · Cited by 19
Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide
Iwama, T., Horie, K., Yoshikawa, T., Nobuoka, D., Shimomura, M., SAWADA, Y., & Nakatsura, T. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1793 · Cited by 19
Laminin α5-derived peptides modulate the properties of metastatic breast tumour cells
Kusuma, N., Anderson, R. L., & Pouliot, N. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9422-8 · Cited by 19
Clinical Significance of the Serum Crosslinked N-Telopeptide of Type I Collagen as a Prognostic Marker for Non–Small-Cell Lung Cancer
Tamiya, M., Kobayashi, M., Morimura, O., Yasue, T., Nakasuji, T., Satomu, M., Kohei, O., Shiroyama, T., Morishita, N., Suzuki, H., et al. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2012.03.012 · Cited by 17
Elevated Serum Endostatin Levels are Associated with Poor Survival in Patients with Advanced-stage Nasopharyngeal Carcinoma
Mo, H., Luo, D., Qiu, H.-Z., Liu, H., Chen, Q.-Y., Tang, L., Zhong, Z.-L., Huang, P., Zhao, Z.-J., Zhang, C., et al. (2013) · Clinical Oncology · doi:10.1016/j.clon.2012.11.009 · Cited by 17
Regulation of p38 MAP kinase by anastellin is independent of anastellin's effect on matrix fibronectin
You, R., Klein, R. M., Zheng, M., & McKeown‐Longo, P. J. (2009) · Matrix Biology · doi:10.1016/j.matbio.2009.01.003 · Cited by 17
Correlations between serum levels of vascular endothelial growth factor and endostatin with clinical pathological characteristics of patients with gastrointestinal cancers.
Li, M., Liu, F., Sun, P., Gao, Y., Chen, H., Liu, H., Wang, M., Chen, J., & Zhao, Y.-A. (2012) · PubMed · doi:10.5754/hge10602 · Cited by 16
Elevated serum endostatin levels are associated with favorable outcome in acute myeloid leukemia
Aref, S., El-Sherbiny, M., Azmy, E., Goda, T., Selim, T. E., El-Refaie, M., & Twafik, E. (2008) · Hematology · doi:10.1179/102453308x315898 · Cited by 16
Canstatin induces apoptosis in gastric cancer xenograft growth in mice through the mitochondrial apoptotic pathway
Xing, Y., Deng, P., & Xu, H. (2014) · Bioscience Reports · doi:10.1042/bsr20140012 · Cited by 15
Recombinant canstatin inhibits VEGF‐A‐induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC‐VII animal model
Hwang‐Bo, J., Park, J., Bae, M. G., & Chung, I. S. (2016) · Cancer Medicine · doi:10.1002/cam4.866 · Cited by 15
Serum concentrations of laminin γ2 fragments in patients with head and neck squamous cell carcinoma
Kuratomi, Y., Satoh, S., Monji, M., Shimazu, R., Tanaka, G., Yokogawa, K., Inoue, A., Inokuchi, A., & Katayama, M. (2008) · Head & Neck · doi:10.1002/hed.20838 · Cited by 14
Novel functions for Type II procollagen
Sandell, L. J. (2014) · Connective Tissue Research · doi:10.3109/03008207.2013.867340 · Cited by 11
Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis
Liu, B., Zhao, Y. J., Yuan, J., Zeng, L., Sun, R., Meng, X., & Yang, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187860 · Cited by 10
Elevated preoperative serum levels of collagen I carboxyterminal telopeptide predict better outcome in early-stage luminal-B-like (HER2-negative) and triple-negative subtypes of breast cancer
Jääskeläinen, A., Jukkola‐Vuorinen, A., Risteli, J., Haapasaari, K., & Karihtala, P. (2019) · Tumor Biology · doi:10.1177/1010428319847081 · Cited by 10
Serum laminin P1 in small cell lung cancer: a valuable indicator of distant metastasis?
Nakano, T., Iwahashi, N., Maeda, J., Hada, T., & Higashino, K. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.123 · Cited by 9
Urine Laminin P1 Assessment Discriminates between Invasive and Noninvasive Urothelial Cell Carcinoma of the Bladder
Farha, K. M. M. A., Menheere, P. P. C. A., Nieman, F. H. M., Janknegt, R. A., & Arends, J. W. (2010) · Urologia Internationalis · doi:10.1159/000282545 · Cited by 9
Syndecan-2 Methylation as a New Biomarker for Early Detection of Colorectal Neoplasm
Kim, J. H., & Park, S. C. (2018) · Gut and Liver · doi:10.5009/gnl18286 · Cited by 9
Serum crosslinked-N-terminal telopeptide of type I collagen (NTx) has prognostic implications for patients with initial prostate carcinoma (PCa): A pilot study
Jablonka, F., Alves, B. D. C. A., de Oliveira, C. G. B., Wroclawski, M. L., Szwarc, M., Vitória, W. D. O., Fonseca, F., & del Giglio, A. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.06.025 · Cited by 8
Interaction of Restin with transcription factors
Wu, Y., Lü, F., Qi, Y.-X., Wang, R., Zhang, J., Lu, Z., & Zhao, Z. (2005) · Science in China Series C Life Sciences · doi:10.1007/bf03183619 · Cited by 5
Diagnostic Values of sVEGFR-1 and Endostatin in Malignant Pleural Effusions in Patients with Lung Cancer
Zhu, Y., Wu, H., & Liu, R. (2017) · Clinical Laboratory · doi:10.7754/clin.lab.2017.170217 · Cited by 5
Correction: Perlecan/HSPG2 and matrilysin/MMP-7 as indices of tissue invasion: tissue localization and circulating perlecan fragments in a cohort of 288 radical prostatectomy patients
Grindel, B. J., Li, Q., Arnold, R. S., Petros, J. A., Zayzafoon, M., Muldoon, M., Stave, J. W., Chung, L. W. K., & Farach‐Carson, M. C. (2016) · Oncotarget · doi:10.18632/oncotarget.11976 · Cited by 4
P135 Discovery and validation of novel biomarkers for detection of epithelial ovarian cancer
Kulbe, H., Otto, R., Darb‐Esfahani, S., Lammert, H., Abobaker, S., Welsch, G., Chekerov, R., Schäfer, R., Dragun, D., Hummel, M., et al. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2019-esgo.197 · Cited by 1

Flagged first, then by citations

Sorted by citations

Immune Checkpoint Inhibitors in Cancer Therapy
Shiravand, Y., Khodadadi, F., Kashani, S. M. A., Hosseini-Fard, S. R., Hosseini, S., Sadeghirad, H., Ladwa, R., O’Byrne, K., & Kulasinghe, A. (2022) · Current Oncology · doi:10.3390/curroncol29050247 · Cited by 1,353
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology
de Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D. W., Gill, S. E., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 572
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 454
Scaffold-based 3D cell culture models in cancer research
Abuwatfa, W. H., Pitt, W. G., & Husseini, G. A. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-00994-y · Cited by 372
The Functional Role of Extracellular Matrix Proteins in Cancer
Popova, N. V., & Jücker, M. (2022) · Cancers · doi:10.3390/cancers14010238 · Cited by 300

See all 349

Authors: Brassart-Pasco, S., Brézillon, S., Brassart, B., Ramont, L., Oudart, J.-B., & Monboisse, J. C.
Affiliations: Centre National de la Recherche Scientifique (FR)
ORCID: Brézillon, Stéphane
Brassart, Bertrand
Ramont, Laurent
Oudart, Jean-Baptiste
Venue: Frontiers in Oncology
Publisher: Frontiers Media SA
Published: 2020-04-15
Volume: 10
Pages: 397-397
ISSN: 2234-943X (ISSN-L)
DOI: 10.3389/fonc.2020.00397
PMC: PMC7174611
OpenAlex: W3016553015
Cited by: 335
References: 168
Citations by year: 2026: 48 · 2025: 53 · 2024: 62 · 2023: 46 · 2022: 65 · 2021: 46 · 2020: 13
FWCI: 4.69
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Frontiers in Oncology (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
HAL (submittedVersion)
HAL (submittedVersion, other-oa)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders: Centre National de la Recherche Scientifique (UMR 7369)
Université de Reims Champagne-Ardenne
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords: tumor microenvironment, extracellular matrix, tumor progression, proteoglycans, matrikines, protease degradation, hypoxia, acidosis, cell invasion, metastasis, prognostic factors, angiogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tumor Microenvironment: Extracellular Matrix Alterations Influence Tumor Progression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks